Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Novella, OSI Pharmaceuticals To Expand Clinical Service Agreement
Reportedly, Novella will assume the use of some of OSI’s facilities in Boulder and employ members of OSI’s Boulder staff. OSI had previously announced plans to consolidate its
Reportedly, Novella will assume the use of some of OSI’s facilities in Boulder and employ members of OSI’s Boulder staff. OSI had previously announced plans to consolidate its
CAMH has applied for international patent protection for the diagnostic test designed by its scientist, Dr. John Vincent and co-inventors, and being developed by Athena Diagnostics. CAMH said
Reportedly, Eden, which will be a part of global brands division of Watson, will maintain its established contract services model, while providing the company with biopharmaceutical development and
As per the alliance, Quintiles is expected to execute a comprehensive commercial sales effort for the product launch and provide additional services in consulting, market access, market intelligence
C5a receptor is a component of the body’s complement system and a potent driver of the inflammatory response associated with autoimmune diseases, such as systemic lupus erythematosus, certain
The study results demonstrated that Rotarix prevented the disease in 61.2% of these infants. It also showed that Rotarix provided broad protection against diverse circulating rotavirus strains and
Allowed claims cover the method of protecting a mammal from radiation using flagellin or its derivatives, including Protectan CBLB502. The US, nine member countries of the Eurasian Patent
CTS-1027 is an oral, small molecule compound that inhibits the activity of key members of a class of protease enzymes, the matrix metalloproteinases or MMPs. CTS-1027’s anti-inflammatory and
Unisource’s uLABEL brand is a Forest Stewardship Council (FSC) Chain-of-Custody certified label paper, that is now available for customer delivery. Jeff Hederick, vice president of global sourcing at
Jack Talley, president and chief executive officer of EpiCept, said: “NP-1’s orphan drug designation is another indication of the significant need that exists for new and more effective